Document is current
Any future updates will be listed below
-
Authors
Reinert, Jochim https://orcid.org/0000-0002-8726-7095
Beitzen-Heineke, Antonia
Wethmar, Klaus
Stelljes, Matthias
Fiedler, Walter
Schwartz, Stefan
-
Funding
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 10 April 2021
Accepted: 4 July 2021
First Online: 31 July 2021
Declarations
:
: All patients provided consent to observational registry trail of the GMALL study group or German registry for stem cell transplantation (DRST), which were approved by ethical committees. All procedures in this study involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: All patients provided consent to collection of data within observational registry trial of the GMALL study group or German registry for stem cell transplantation (DRST).
: All patients provided consent to publication of anonymized data within observational registry trial of the GMALL study group or German registry for stem cell transplantation (DRST).
: W.F. declares membership on an entity’s board of directors or advisory committee for AbbVie, Amgen, ARIAD/Incyte, Celgene, Jazz Pharmaceuticals, MorphoSys AG, Novartis and Pfizer; patents and royalties from Amgen; support for meeting attendance Amgen, Daiichi Sankyo, Gilead, Jazz Pharmaceuticals and Servier; and research funding from Amgen and Pfizer. M.S. declares research support and honoraria from Pfizer. S.S. declares personal fees from BTG Intl Inc., MSD Sharp & Dohme, Novartis and Pfizer; personal fees and non-financial support from AMGEN, Gilead Sciences and Jazz Pharmaceuticals; and non-financial support from Basilea.
